John W. Kooyman Sells 19,683 Shares of Colgate-Palmolive (NYSE:CL) Stock

Colgate-Palmolive (NYSE:CLGet Rating) insider John W. Kooyman sold 19,683 shares of the company’s stock in a transaction that occurred on Monday, May 16th. The stock was sold at an average price of $78.49, for a total transaction of $1,544,918.67. Following the completion of the transaction, the insider now owns 7,007 shares in the company, valued at $549,979.43. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

CL stock traded down $3.06 on Wednesday, reaching $75.71. The company’s stock had a trading volume of 4,590,242 shares, compared to its average volume of 5,556,381. The business has a fifty day simple moving average of $77.43 and a two-hundred day simple moving average of $79.17. Colgate-Palmolive has a 12-month low of $72.20 and a 12-month high of $85.61. The firm has a market cap of $63.44 billion, a PE ratio of 31.41, a PEG ratio of 5.24 and a beta of 0.56. The company has a debt-to-equity ratio of 10.42, a quick ratio of 0.67 and a current ratio of 1.09.

Colgate-Palmolive (NYSE:CLGet Rating) last announced its quarterly earnings results on Friday, April 29th. The company reported $0.74 EPS for the quarter, hitting analysts’ consensus estimates of $0.74. Colgate-Palmolive had a return on equity of 296.77% and a net margin of 11.70%. The company had revenue of $4.40 billion during the quarter, compared to analyst estimates of $4.40 billion. During the same quarter last year, the firm posted $0.80 earnings per share. The firm’s revenue was up 1.3% on a year-over-year basis. As a group, research analysts anticipate that Colgate-Palmolive will post 3.08 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its Board of Directors has approved a share repurchase program on Thursday, March 10th that allows the company to repurchase $5.00 billion in shares. This repurchase authorization allows the company to buy up to 8.1% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s leadership believes its stock is undervalued.

The firm also recently declared a quarterly dividend, which was paid on Friday, May 13th. Investors of record on Thursday, April 21st were paid a $0.47 dividend. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.45. The ex-dividend date was Wednesday, April 20th. This represents a $1.88 dividend on an annualized basis and a yield of 2.48%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 77.69%.

A number of hedge funds have recently made changes to their positions in CL. Bank of New Hampshire increased its holdings in shares of Colgate-Palmolive by 0.5% during the first quarter. Bank of New Hampshire now owns 24,551 shares of the company’s stock valued at $1,862,000 after acquiring an additional 123 shares in the last quarter. Avantax Planning Partners Inc. increased its holdings in Colgate-Palmolive by 1.3% in the 4th quarter. Avantax Planning Partners Inc. now owns 9,719 shares of the company’s stock worth $829,000 after buying an additional 129 shares in the last quarter. Meridian Wealth Management LLC increased its holdings in Colgate-Palmolive by 3.4% in the 4th quarter. Meridian Wealth Management LLC now owns 3,946 shares of the company’s stock worth $337,000 after buying an additional 131 shares in the last quarter. Somerset Trust Co increased its holdings in Colgate-Palmolive by 0.5% in the 4th quarter. Somerset Trust Co now owns 25,737 shares of the company’s stock worth $2,196,000 after buying an additional 132 shares in the last quarter. Finally, Mission Wealth Management LP increased its holdings in Colgate-Palmolive by 3.0% in the 4th quarter. Mission Wealth Management LP now owns 4,560 shares of the company’s stock worth $389,000 after buying an additional 134 shares in the last quarter. 78.12% of the stock is owned by institutional investors.

CL has been the topic of several research analyst reports. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $78.00 to $76.00 and set an “underweight” rating on the stock in a research report on Monday, January 31st. Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $82.00 target price for the company. in a research note on Monday, May 2nd. TheStreet raised Colgate-Palmolive from a “c+” rating to a “b” rating in a research note on Friday, April 29th. Stifel Nicolaus cut their target price on Colgate-Palmolive from $90.00 to $88.00 in a research note on Wednesday, April 13th. Finally, JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $86.00 to $81.00 and set a “neutral” rating for the company in a research note on Wednesday, March 30th. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Hold” and an average price target of $85.56.

Colgate-Palmolive Company Profile (Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.